Rosy Favicchio

Medicine · Health Sciences

10h-index449citations44works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(17), Cancer, Hypoxia, and Metabolism(15), Optical Imaging and Spectroscopy Techniques(15), Photoacoustic and Ultrasonic Imaging(13), Metabolism, Diabetes, and Cancer(7)

Publications44 total

Supplementary Figure 5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 2 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Data from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 1 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 3 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 6 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Data from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Tables 1-5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 2 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 4 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 1 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 6 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 3 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 4 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Tables 1-5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth
Hepatology·2021· 20 citedOpen Access
Extracellular vesicles swarm the cancer microenvironment: from tumor–stroma communication to drug intervention
Oncogene·2016· 138 cited
Abstract 4235: Choline metabolism is an early predictor of EGFR-mediated survival in NSCLC
Cancer Research·2016· 1 cited
The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth
Oncotarget·2016· 43 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Eric O. Aboagye(20), Juan Carlos Lacal(18), José M. Mazarico(17), Víctor J. Sánchez‐Arévalo Lobo(17), William Greenhalf(17), Eithne Costello(17), Francisco X. Real(17), Giannis Zacharakis(16), Enrique Carrillo-de Santa Pau(16), Miriam Marqués(16), Jorge Ripoll(15), Clio Mamalaki(7), Anikitos Garofalakis(7), Georgios Giamas(6), Stylianos Psycharakis(6), Justin Stebbing(4), Diana Bričkutė(3), Robin Fortt(3), Frazer Twyman(3), George Spiliopoulos(3)